Germany
Japan
United Kingdom
China
Recombinant Anti-CD28 (Clone 15E8)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadPdcd4 phospho S457 Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Stat5 phospho Y694 Antibody
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
AKT phospho S473 Antibody
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
AKT phospho T308 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Active filters
Isotypes
- IgG1, kappa
Assay Types
- Indirect
Filter by
Category
Target Symbol
- EGFR (4)
- TNF (3)
- VEGFA (3)
- AKT1 (2)
- CCR5 (2)
- CD28 (2)
- CD4 (2)
- CD52 (2)
- ERBB2 (2)
- FN1 (2)
- IL2RA (2)
- LEY (2)
- MSLN (2)
- MUC1 (2)
- N (2)
- NOTCH2 (2)
- PXN (2)
- SLC3A2 (2)
- TIMD4 (2)
- ACKR1 (1)
- ADORA2A (1)
- ADRB2 (1)
- AGER (1)
- AOC3 (1)
- APP (1)
- BETVI (1)
- BSG (1)
- C3AR1 (1)
- CD1A (1)
- CD40LG (1)
- CD74 (1)
- CD81 (1)
- COX1 (1)
- CR1 (1)
- DDR1 (1)
- DSRNA (1)
- EDAR (1)
- EPHA2 (1)
- F (1)
- FAS (1)
- FCAR (1)
- FGB (1)
- G1 (1)
- GAL (1)
- GYPA (1)
- IFNG (1)
- IGE (1)
- IGM (1)
- IL10 (1)
- IL17A (1)
- IL18 (1)
- IL2 (1)
- IL4 (1)
- IL6R (1)
- IL9 (1)
- INSR (1)
- ITGA4 (1)
- ITGA5 (1)
- ITGAM (1)
- ITGAX (1)
- MMP14 (1)
- NCAM1 (1)
- NTRK1 (1)
- PDCD4 (1)
- PRION (1)
- PROC (1)
- RAP (1)
- RHO (1)
- S (1)
- SEPTIN5 (1)
- SIRPG (1)
- SNAP25 (1)
- STAT5A (1)
- TF (1)
- TNFRSF10B (1)
- TNFRSF8 (1)
- TNFRSF9 (1)
- TNFSF18 (1)
- TRAC (1)
- TSPAN1 (1)
- TYRP1 (1)
- VSIR (1)
Reactivities
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (5)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)